T1	intervention 10 22	Rosuvastatin
T2	condition 37 72	Chemotherapy-Induced Cardiotoxicity
T3	total-participants 661 663	89
T4	eligibility 664 747	women with newly diagnosed breast cancer who were scheduled to receive chemotherapy
T5	control 810 817	placebo
T8	outcome 1365 1369	LVEF
T9	outcome 1532 1536	LVEF
T10	outcome 1701 1752	4- and 2-chamber LVESV, LA diameter, and E/e' ratio
T11	outcome 1878 1898	e' and s' velocities
